Pro Dex Inc (PDEX) stock
PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/3012% below fair value
$61.93−2.55 (-3.95%)
Close on Nov 17, 2026Market cap $198.18MP/E 17.1Yield –
Pro Dex operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Pro Dex's operating income for the twelve months ending Sep 30, 2026 was $13.40M, up 24.2% year over year. For fiscal 2026 it was $12.99M, up 21.5% from the year before. Over ten years it grew 32.0% a year on average. The highest annual figure on record is $12.99M in fiscal 2026.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $12.99M | +21.5% |
| FY2025 | Jun 30, 2025 | $10.69M | +49.0% |
| FY2024 | Jun 30, 2024 | $7.17M | +24.5% |
| FY2023 | Jun 30, 2023 | $5.76M | +12.5% |
| FY2022 | Jun 30, 2022 | $5.12M | +13.2% |
| FY2021 | Jun 30, 2021 | $4.53M | -36.0% |
| FY2020 | Jun 30, 2020 | $7.07M | +41.4% |
| FY2019 | Jun 30, 2019 | $5.00M | +108.9% |
| FY2018 | Jun 30, 2018 | $2.39M | -12.6% |
| FY2017 | Jun 30, 2017 | $2.74M | +239.2% |
| FY2016 | Jun 30, 2016 | $807.00K | – |
| FY2015 | Jun 30, 2015 | -$902.00K | – |
| FY2014 | Jun 30, 2014 | -$814.00K | – |
| FY2013 | Jun 30, 2013 | -$1.90M | – |
| FY2012 | Jun 30, 2012 | -$1.37M | -139.2% |
| FY2011 | Jun 30, 2011 | $3.48M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $3.52M | +13.1% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $3.53M | +162.6% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $3.09M | -15.0% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $3.26M | +21.1% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $3.11M | +3.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.34M | -42.8% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $3.64M | +64.5% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $2.69M | +246.5% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $3.01M | +64.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $2.35M | +46.0% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $2.21M | +7.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $777.00K | -31.7% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $1.83M | +92.9% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $1.61M | +36.1% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $2.07M | +102.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $1.14M | -29.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $950.00K | -27.9% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $1.18M | +100.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $1.02M | -45.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $1.60M | +207.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $1.32M | -14.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $590.00K | -73.2% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $1.87M | +9.4% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $521.00K | -68.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $1.55M | +3.9% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.20M | +86.6% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $1.70M | +90.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $1.67M | +39.8% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $1.49M | -13.7% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $1.18M | +120.6% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $897.00K | +41.9% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $1.19M | +240.9% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $1.73M | +97.7% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $535.00K | -35.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $632.00K | -53.1% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $350.00K | +30.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $874.00K | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $826.00K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $1.35M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $269.00K | – |
See a number that looks wrong?